Primary Site >> Colorectal Cancer
Gene >> CDC25B
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. PMID: 10850455 |
Ref: Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. PMID: 11304565 Ref: [Future scope for gene therapy for liver metastasis of colon cancer]. PMID: 11394006 Ref: [Tumor markers for colorectal cancer]. PMID: 11579645 |
Ref: Synthesis and biological evaluation of dimeric cinnamaldehydes as potent antitumor agents. PMID: 16343908 Ref: Biochemical and clinical approaches in evaluating the prognosis of colon cancer. PMID: 17214335 |
Ref: Anthraquinones, Cdc25B phosphatase inhibitors, isolated from the roots of Polygonum multiflorum Thunb. PMID: 17497420 |
Ref: Wild-type p53 and p73 negatively regulate expression of proliferation related genes. PMID: 17982488 Ref: Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents. PMID: 18635965 |
Ref: Hypoxia-mediated regulation of Cdc25A phosphatase by p21 and miR-21. PMID: 19738433 |
Ref: Contributions made by CDC25 phosphatases to proliferation of intestinal epithelial stem and progenitor cells. PMID: 21283624 |
Ref: MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer. PMID: 25297629 |
Ref: Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization. PMID: 26918318 |
Ref: BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers. PMID: 27447746 |